Literature DB >> 19328248

The 8q22.1 microdeletion syndrome or Nablus mask-like facial syndrome: report on two patients and review of the literature.

Annick Raas-Rothschild1, Trijnie Dijkhuizen, Birgit Sikkema-Raddatz, Marion Werner, Judith Dagan, Devorah Abeliovich, Israela Lerer.   

Abstract

Nablus mask-like facial syndrome (NMFLS) is a rare microdeletion syndrome with a mask-like facial appearance as the most characteristic feature. In 2000, Teebi, was the first to report on a 4 years old boy affected with NMFLS. Since then two additional patients have been reported. Three years later, with the development of the array CGH technology, Shieh et al., elucidated the etiology of NMFLS by showing that the two patients studied share a approximately 4 Mb microdeletion in the long arm of chromosome 8 (q21.3-q22.1). Here we report on two NMFLS patients among which the first patient described by Teebi in 2000, and present newly described clinical findings including the common happy behaviour of the children. Array CGH analysis of these two patients permitted to reveal a deletion in the same region, 8q21.3-q22.1. Combining the available literature and our data, we were able to narrow the common deleted region to 2.78 Mb (93.56-96.34 Mb) in 8q22.1. Direct relations between the clinical findings with (one of) the genes in the critical region have to await further studies on NFMLS patients with overlapping or smaller deletions.

Entities:  

Mesh:

Year:  2009        PMID: 19328248     DOI: 10.1016/j.ejmg.2009.03.011

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  3 in total

1.  Nablus Mask-Like Facial Syndrome with Moderate Developmental Delay.

Authors:  Bahadir Turan; Mehmet Akif Akinci; Ibrahim Selcuk Esin; Onur Burak Dursun
Journal:  Eurasian J Med       Date:  2020-06-02

2.  The BMP ligand Gdf6 prevents differentiation of coronal suture mesenchyme in early cranial development.

Authors:  Dawn E Clendenning; Douglas P Mortlock
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

Review 3.  A framework for the evaluation of patients with congenital facial weakness.

Authors:  Bryn D Webb; Irini Manoli; Elizabeth C Engle; Ethylin W Jabs
Journal:  Orphanet J Rare Dis       Date:  2021-04-07       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.